AU2002356352A1 - Use of 5-chloro-4-(3-(n-(2-(3,4-dimethoxy-phenyl)-ethyl)-n-methylamino)-propylamino)-3-(2h)-pyridazinone as metabolic modulator - Google Patents
Use of 5-chloro-4-(3-(n-(2-(3,4-dimethoxy-phenyl)-ethyl)-n-methylamino)-propylamino)-3-(2h)-pyridazinone as metabolic modulatorInfo
- Publication number
- AU2002356352A1 AU2002356352A1 AU2002356352A AU2002356352A AU2002356352A1 AU 2002356352 A1 AU2002356352 A1 AU 2002356352A1 AU 2002356352 A AU2002356352 A AU 2002356352A AU 2002356352 A AU2002356352 A AU 2002356352A AU 2002356352 A1 AU2002356352 A1 AU 2002356352A1
- Authority
- AU
- Australia
- Prior art keywords
- pyridazinone
- propylamino
- methylamino
- dimethoxy
- chloro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- UUMQGMCYAJYYQR-UHFFFAOYSA-N 4-chloro-5-[3-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]propylamino]-1h-pyridazin-6-one Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)CCCNC1=C(Cl)C=NNC1=O UUMQGMCYAJYYQR-UHFFFAOYSA-N 0.000 title 1
- 230000002503 metabolic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/22—Nitrogen and oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HUP0202993 | 2002-09-11 | ||
HU0202993A HU227181B1 (en) | 2002-09-11 | 2002-09-11 | Use of 5-chloro-4-[3-[n-[2-(3,4-dimethoxyphenyl)ethyl)]-n-methylamino]-propylamino]-3-(2h)-pyridazinone for producing pharmaceutical compositions having metabolic modulator effect |
PCT/HU2002/000172 WO2004024158A1 (en) | 2002-09-11 | 2002-12-28 | Use of 5-chloro-4-[3-[n-[2-(3,4-dimethoxy-phenyl)-ethyl]-n-methylamino]-propylamino]-3-(2h)-pyridazinone as metabolic modulator |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002356352A1 true AU2002356352A1 (en) | 2004-04-30 |
Family
ID=89980763
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002356352A Abandoned AU2002356352A1 (en) | 2002-09-11 | 2002-12-28 | Use of 5-chloro-4-(3-(n-(2-(3,4-dimethoxy-phenyl)-ethyl)-n-methylamino)-propylamino)-3-(2h)-pyridazinone as metabolic modulator |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2002356352A1 (en) |
HU (1) | HU227181B1 (en) |
WO (1) | WO2004024158A1 (en) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU214320B (en) * | 1991-12-20 | 1998-03-02 | EGIS Gyógyszergyár Rt. | Process for producing novel 3(2h)-pyridazinon derivatives and pharmaceutical compositions producing them |
HUP0103064A3 (en) * | 2001-07-26 | 2005-06-28 | Egis Gyogyszergyar Nyilvanosan | Polymorphic form of 5-chloro-4-(3-{[2-(3,4-dimethoxy-phenyl)-ethyl]-methyl-amino]-propylamino)-3-(2h)-piridazinone fumarate, its use, process for its preparation and pharmaceutical compositions containing it |
-
2002
- 2002-09-11 HU HU0202993A patent/HU227181B1/en not_active IP Right Cessation
- 2002-12-28 AU AU2002356352A patent/AU2002356352A1/en not_active Abandoned
- 2002-12-28 WO PCT/HU2002/000172 patent/WO2004024158A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
HUP0202993A2 (en) | 2004-06-28 |
HU0202993D0 (en) | 2002-11-28 |
HUP0202993A3 (en) | 2004-10-28 |
WO2004024158A1 (en) | 2004-03-25 |
HU227181B1 (en) | 2010-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AP1660A (en) | Crystals including a malic acid salt of N - [2 -(diethylamino) ethyl] - 5 - [ (5 - fluoro -2-oxo - 3H -indole -3 - ylidene) methyl] - 2,4 - dimethyl - 1H- pyrrole -3 -carboxamide, processes for its preparation and compositions thereof. | |
AP2003002836A0 (en) | 3-(4-Amidopyrrol-2-ylmethlidene)-2-indolinone derivatives as protein kinase inhibitors. | |
EP1828143A4 (en) | 2-(phenyl or heterocyclic)-1h-phenantrho[9,10-d]imidazoles as mpges-1 inhibitors | |
DK1353917T3 (en) | New Process for the Synthesis of 5- (4-Fluorophenyl) -1- [2 - ((2R, 4R) -4-hydroxy-6-oxo-tetrahydro-pyran-2-yl) ethyl] -2-isopropyl-4 -phenyl-1H-pyrrole-3-carboxylic acid phenylamide | |
SI1870100T1 (en) | Ethyl 3-(2-(4-(hexyloxycarbonylamidino)phenylaminomethyl)-1-methyl-1H-benzimidazole-5-carbonyl)-2-pyridylamino)propionate methansulfonate | |
DK1443955T3 (en) | PDGF-BB for the treatment of Parkinson's disease | |
AU2003299362A1 (en) | Derivative of 5-(4-bromophenyl)-1-(2,4-dichlorophenly)-4-ethyl-n-(piperidine-1-yl)-1h-pyrazol-3-carboxamide, the preparation and therapeutic use thereof | |
WO2003047520A3 (en) | SUBSTITUTED AMINO METHYL FACTOR Xa INHIBITORS | |
IL184059A0 (en) | Crystal and salt of 1-cyclopropylmethyl-4-[2-(3,3,5,5)-tetramethylcyclohexylphenyl]piperazine | |
IL188483A0 (en) | Crystalline forms of 4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]-3-quinolinecarb-onitrile and methods of preparing the same | |
PL1632232T6 (en) | Salt of 4[[4-[[4-(2-Cyanoethenyl)-2,6-dimethylphenyl]amino]-2-Pyrimidinyl]amino]benzonitrile | |
AU2003294479A1 (en) | Modulation of cytokine-inducible kinase expression | |
IS2473B (en) | Composition containing N- (3-methoxy-5-methylpyrazin-2-yl) -2- (4- (1,3,4-oxadiazol-2-yl) phenyl) pyridine-3-sulfonamide (ZD4054), or pharmaceutically its recognized salt, and EGFR TKI, or its pharmaceutically acceptable salt | |
AU2003269885A1 (en) | Antisense modulation of g protein-coupled receptor kinase 6 expression | |
IL164413A0 (en) | (2-((-Alkoxy)-phenyl)-cyclopent-1-enyl)aromatic carbo and heterocyclic acid and derivatives | |
HK1006359A1 (en) | Salts of ethyl 3-(2-(4-(4-(amino-imino-methyl)phenyl)-4-methyl-2, 5-dioxo -imidazoldin-1-yl)acetylamino)-3 -phenylpropionate | |
AU2003212979A1 (en) | Substituted fused pyrazolecarboxylic acid arylamides and related compounds | |
AU2002356352A1 (en) | Use of 5-chloro-4-(3-(n-(2-(3,4-dimethoxy-phenyl)-ethyl)-n-methylamino)-propylamino)-3-(2h)-pyridazinone as metabolic modulator | |
AU2003257407A1 (en) | S-(+)-3-{1-(2-(2,3-dihydro-1h-indol-3-yl)ethyl)-3,6-dihydro-2h-pyridin-4-yl}-6-chloro-1h-indole and acid addition salts thereof | |
AU2001290743A1 (en) | Solid salt forms of n-(2-(4-(2-(1-methylethoxy)phenyl)-1-piperazinyl)ethyl)-2-oxo-1-piperidineacetamide | |
HUP0103064A3 (en) | Polymorphic form of 5-chloro-4-(3-{[2-(3,4-dimethoxy-phenyl)-ethyl]-methyl-amino]-propylamino)-3-(2h)-piridazinone fumarate, its use, process for its preparation and pharmaceutical compositions containing it | |
AU2003297554A1 (en) | Modulation of death-associated protein kinase 1 expression | |
AU2003236510A1 (en) | Antisense modulation of ptpn12 expression | |
AU1572201A (en) | Crystalline salts of (S)-4-(3-(N-(2-(4-(5-carbamoyl-2-pyridyloxy)phenyl)-1,1- dimethylethyl)amino)-2-hydroxypropoxy)indole | |
EP1434570B8 (en) | Pharmaceutical formulations for the controlled release of 4-amino-6,7-dimethoxy-2-(5-methanesulfonamido-1,2,3,4-tetrahydroisoquinol-2-yl)-5-(2-pyridyl)quinazoline |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |